Unbound MEDLINE

Management of the ageing eyebrow and forehead: an objective dose-response study with botulinum toxin. Journal of the European Academy of Dermatology and Venereology : JEADV. [J Eur Acad Dermatol Venereol] Journal article

 
TitleManagement of the ageing eyebrow and forehead: an objective dose-response study with botulinum toxin.
Author(s)Levy J, Pons F, Jouve E 
InstitutionCentre Laser Dermatologique, Marseille, France.
SourceJ Eur Acad Dermatol Venereol 2006 Jul; 20(6):711-6.
AbstractObjective To determine if clinical use of two different doses of botulinum exotoxin A (BTX-A) injections to the forehead area result in wrinkle reduction and modifications of eyebrow position. Design Prospective study. Setting Private practice, Dermatologic Laser Centre, Marseille, France. Subjects Twenty-four adult patients treated with BTX-A (Vistabel(R)) injections for forehead rhytides. Intervention Of the 24 patients, 12 received BTX-A injections of 5 U only and 12 received injections of 10 U into the forehead, with or without treatment of the lateral forehead. The eyebrow position, forehead height and number of forehead lines determine the number of injection points. Patients were evaluated before injection and every 2 months after treatment during next 8 months. Results In the two groups of 12 patients, we found no significant change between the two doses. At each time after injections (every 2 months until 8 months), both groups showed a statistically significant improvement except at 8 months. Both groups exhibited the same results on standardized photos and on 3D skin profilometry. Conclusions The two doses of BTX-A injections into the forehead gave the same results. The duration of the effect is similar along 8 months. This study emphasizes the role of low doses of BTX-A injections to obtain good clinical results without freezing aspect.
Languageeng
Pub Type(s)Journal Article
PubMed ID16836501
  
Advertise on this site.